Major Medical Devices, is a medical technology company dedicated to developing innovative vascular intervention solutions that improve outcomes and broaden treatment options for abdominal aortic aneurysms (AAA). Its flagship AAA device integrates novel design and deployment technologies aimed at setting a new standard in endovascular aneurysm repair (EVAR). The technology is highly differentiated, potentially quick to market in a $3 billion market.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/09/26 | undisclosed | Strategic |
TCA Venture Group | undisclosed |
